Cyberdyne Inc (CYBQY) fair value: what the stock is really worth
As of Oct 28, 2026: fair value (intrinsic value) of Cyberdyne Inc stock $0.42, price $1.35, upside -68.9%, quality 57 out of 100. Rating: strongly overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with oneYes, for free
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Oct 28, 2026.
How to read this chart
60‑month range $0.8810 – $4.26 · fair‑value band $0.3600 – $0.4800 · the $1.35 price screens above the $0.4200 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Oct 28, 2026.
Follow Cyberdyne Inc ADR in your weekly email
Every Wednesday you see whether Cyberdyne Inc ADR is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
CYBERDYNE Inc. researches, develops, produces, sell, leases, and maintains robotic equipment and systems for medical and welfare in Japan, the United States, Europe, the Middle East, Africa, and the Asia Pacific countries.
Show moreShow less
The company offers Hybrid Assistive Limb (HAL) for medical use in lower limb and single joint type; non-medical HAL for lower limb, single joint type, and lumbar type; HAL peripherals; cleaning robots; transportation robots for various transportation tasks in factories, offices, and other indoor environments; Acoustic X, a high-speed light pulse LED array light source that enables real time photoacoustic imaging; and CYIN for living support, which is an interface that uses biological information that can be controlled voluntarily outside of muscle activities.
It also provides Cybernics Treatment, a treatment that uses HAL to enhance and regenerate the function of the wearer for spinal cord injury, stroke, neuromuscular diseases, etc.; Neuro HALFIT for enhancement of brain-nerve-musculoskeltal system; MTX Neuro HAL Plus to enhance the performance of the athletes' brain-nerve functions; and Neuro HALFIT at home for enhancement of physical functions.
In addition, the company provides rescue support in disaster sites, and heavy labor support for factories and plants, as well as engages in the entertainment business. CYBERDYNE Inc. was incorporated in 2004 and is headquartered in Tsukuba, Japan.
Stock analysis
Cyberdyne Inc (CYBQY) currently trades at $1.35, while our model-based Fair Value estimate is $0.4200, 68.9% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Economic Profit group reads highest at a median of $0.6400 per share, and 1 of the 20 models we run sit above the $1.35 price.
Bear case: the Earnings-Based group reads lowest at $0.0600, and 19 of the 20 models stay below the price. Data coverage for this calculation is medium.
Scenario range: $0.3600 (bear) to $0.4800 (bull), the price of $1.35 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 57/100 (solid quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Cyberdyne Inc ADR reported revenue of ¥4.1B in FY2026 versus ¥2.2B in FY2022, a compound +17.4%/yr. Reported net income was ¥162M in FY2026.
Key figures
Market cap $285M Micro · P/E ratio 135.0 · P/S ratio 5.37 · EPS (TTM) $0.0100 · Dividend yield 0.1% · Net margin 4.0% · Return on equity 0.4% · Return on assets (EBIT) −2.5%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 24 out of 100 (low confidence).
What moves the price
The share trades about 42% below its 52-week high and 53% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −8% fair-value upside, at −69%, CYBQY screens richer than that median.
Fair Value models
The price assumes far more growth than our models allow for, so the models scatter widely ($0.0100 to $5.12). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear$0.3600Fair Value $0.4200Bull$0.4800
Price $1.35 · Upside -68.9%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 7 months old). Earnings retained since then ($0.0058 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.79/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−7.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+16.8%
Start year 2021 (pandemic). Over 10 years: +12.4% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+20.0%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−37.3% (2021) → −28.7% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: no profitable base year
not computed
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+63.3%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+14.2%
Yearly sales growth analysts expect, extended to five years.
After inflation (figures in JPY, Japan: IMF forecast 2.1% a year to 2030, 1.3% from 2016 to 2025) that is about +60.0% a year for the price and +11.9% for the forecasts.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 326 stocks
Beats the industry median on 2/12 measures
Overall it trails its industry peers.
Valuation
Quality Score57 · Above median
Fair Value upside−68.9% · Bottom 25%
Profitability
Return on equity (12 months)0.4% · Below median
Return on assets0.3% · Below median
Net margin (12 months)4.0% · Below median
Operating margin (12 months)−1.8% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY)2.7% · Below median
Dividend yield (12 months)0.1% · Bottom 25%
Valuation Multiplesvs Medical Devices median · lower = cheaper
P/E (12 months)135.0× · Priciest 25%
P/B1.13× · Cheaper than median
P/S (12 months)11.61× · Priciest 25%
Price / free cash flow233.0× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 5
FUTURE (revenue growth)14· sector 35
PAST (return on equity)1· sector 16
HEALTH (low debt)100· sector 98
DIVIDEND (yield)2· sector 35
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Cyberdyne Inc (CYBQY) overvalued or undervalued?
As of Oct 28, 2026, our model estimates a fair value of $0.4200 versus a price of $1.35, about −69% upside (overvalued).
What is the fair value of CYBQY?
Our model-based fair value for Cyberdyne Inc ADR is $0.4200 (as of Oct 28, 2026), built from audited fundamentals. The current price: $1.35.
What is the quality score of CYBQY?
Cyberdyne Inc ADR has a Quality Score of 57/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Cyberdyne Inc (CYBQY)?
Our model-based price target is the fair value of $0.4200 (as of Oct 28, 2026) from 20 valuation models. Cautious scenario $0.3600, optimistic scenario $0.4800. It is a calculation from audited fundamentals, not an analyst target.
What is the Cyberdyne Inc ADR stock forecast for 2026?
Our models put fair value at $0.4200, about −69% upside versus a price of $1.35 (overvalued). Cautious scenario $0.3600, optimistic scenario $0.4800. The calculation is refreshed regularly with new filings.
What is the revenue of Cyberdyne Inc (CYBQY)?
Cyberdyne Inc ADR reported trailing-twelve-month revenue of about ¥3.9B (latest available figure, as of Oct 28, 2026).
Does Cyberdyne Inc ADR pay a dividend?
Cyberdyne Inc ADR currently shows a dividend yield of 0.09% relative to its recent price (as of Oct 28, 2026).
What growth is priced into Cyberdyne Inc (CYBQY)?
For today's price to be fair in a discounted-cash-flow model, Cyberdyne Inc ADR would have to grow free cash flow by +63.3 % per year for five years (discount rate 12.2 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +16.8 % per year. As of Oct 28, 2026.
What discount rate (WACC) does the fair value of CYBQY use?
Our models discount Cyberdyne Inc ADR at 12.2 %: a base by market capitalisation (micro), damped by beta 0.84, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Cyberdyne Inc ADR that is +63.3 % per year a year over ten years, using the same discount rate (12.2 %) and the same formula as our fair value.
How much growth has Cyberdyne Inc (CYBQY) delivered so far?
Over the past 5 years revenue at Cyberdyne Inc ADR grew +16.8 % a year. The price currently implies +63.3 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Cyberdyne Inc (CYBQY) growing?
The median revenue growth in the sector is +6.2 % a year. That is the yardstick for the growth priced into Cyberdyne Inc ADR (+63.3 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Cyberdyne Inc (CYBQY)?
The free-cash-flow yield on the price is 0.43 %: that much free cash flow Cyberdyne Inc ADR produces per unit of market value. When it exceeds the discount rate of our models (12.2 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Cyberdyne Inc (CYBQY)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Cyberdyne Inc ADR it is $0.4200 per share (as of Oct 28, 2026), against a price of $1.35. It is the blended result of 20 valuation models (cash flow, earnings, asset, dividend).
Is Cyberdyne Inc ADR stock overvalued or undervalued in 2026?
As of Oct 28, 2026, CYBQY trades above its calculated fair value: price $1.35, fair value $0.4200, a gap of about −69% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CYBQY?
No. The price is what the market pays today ($1.35); the fair value is what the company's own numbers justify ($0.4200). For Cyberdyne Inc ADR the two are $0.9300 per share apart. That gap is exactly why we show both numbers side by side.
How much is Cyberdyne Inc ADR worth?
The market values Cyberdyne Inc ADR at about $285M (market capitalisation, as of Oct 28, 2026). Per share that is $1.35; our models calculate a fair value of $0.4200 per share.
What do the bullish and bearish scenarios say about CYBQY?
Our models span a range for Cyberdyne Inc ADR: cautious scenario $0.3600, base $0.4200, optimistic $0.4800 per share (as of Oct 28, 2026, price $1.35). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of CYBQY?
Cyberdyne Inc ADR trades at a price-to-earnings ratio of 135.0 (as of Oct 28, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $0.4200 is built from several models across several years. Other multiples: P/B 1.1, P/S 11.6.
How solid is the balance sheet of Cyberdyne Inc (CYBQY)?
Balance-sheet figures for Cyberdyne Inc ADR (as of Oct 28, 2026): return on equity 0.4%. They feed the Quality Score of 57/100, which measures business quality independently of the share price.
How far is CYBQY from its 52-week high?
Cyberdyne Inc ADR trades at $1.35, about 42% below its 52-week high of $2.32 and 53% above the low of $0.8810 (as of Oct 28, 2026). Distance from the high says nothing about value: that is what the fair value of $0.4200 is for.
Which stocks are comparable to Cyberdyne Inc ADR?
From the same area (Healthcare) we also value Abbott Laboratories,, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Cyberdyne Inc ADR stock attractive at the current price?
The data as of Oct 28, 2026: price $1.35, calculated fair value $0.4200 (−69%), Quality Score 57/100, from 20 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CYBQY calculated?
We run Cyberdyne Inc ADR through 20 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.4200, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3 % above its aggregate fair value. Cyberdyne Inc ADR itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Cyberdyne Inc (CYBQY)?
The closing price on Oct 28, 2026 was $1.35. Our model-based fair value is $0.4200, about −69% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Cyberdyne Inc ADR right now?
The price sits above even our optimistic bull case ($0.4800). The favourable scenario is already priced in. Solid but not exceptional quality (57/100) and above fair value, neither a clear bargain nor a standout compounder.
Key figures of Cyberdyne Inc ADR
How large is the market capitalisation of Cyberdyne Inc (CYBQY)?
The market capitalisation of Cyberdyne Inc ADR is $285M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Cyberdyne Inc (CYBQY)?
The price-to-sales ratio of Cyberdyne Inc ADR is 5.37 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Cyberdyne Inc (CYBQY)?
Earnings per share at Cyberdyne Inc ADR are $0.0100 (price ÷ EPS = P/E 135.0). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Cyberdyne Inc (CYBQY)?
The dividend yield of Cyberdyne Inc ADR is 0.1% (payout 11.7%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Cyberdyne Inc (CYBQY)?
The net margin of Cyberdyne Inc ADR is 4.0% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Cyberdyne Inc (CYBQY)?
The return on equity (ROE) of Cyberdyne Inc ADR is 0.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Cyberdyne Inc (CYBQY)?
On an EBIT basis the return on assets of Cyberdyne Inc ADR is −2.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Cyberdyne Inc (CYBQY)?
The operating margin of Cyberdyne Inc ADR is −1.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Cyberdyne Inc (CYBQY)?
Revenue at Cyberdyne Inc ADR is growing +2.7% versus a year earlier (3y avg +7.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Cyberdyne Inc (CYBQY)?
Earnings per share at Cyberdyne Inc ADR are growing +48.9% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Cyberdyne Inc (CYBQY) hold?
Cyberdyne Inc ADR holds more cash than debt, ¥8.3B net (fiscal year 2026). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Cyberdyne Inc ADR in the live analysis
One click puts Cyberdyne Inc ADR on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Some data
Oct 28, 2026